Renal Allograft Failure

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-11-06
Clinical Trial Update: Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure [Phase 4]
This Phase 4 clinical trial compares continued immunosuppression versus stopping immunosuppression at six months in patients with late renal…